Escient Pharmaceuticals is a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.

Biotechnology

Escient Pharmaceuticals

Gregg Timony

Michelle Solomon PhD

David Houck

Veena Viswanath

Terri Kim

Christian Weyer

Beatrice Ferguson

Kathleen Sereda Glaub

Marion Lanier

Tonya Haugen

Kristin Taylor

Aaron Mishel

Jennifer Brooks

The Research and Development team at Escient Pharmaceuticals is responsible for the discovery and advancement of innovative GPCR-targeted therapeutics. Comprised of scientists and advisors, the team collaborates to conduct cutting-edge research, optimize drug formulations, and translate scientific findings into viable treatment options, focusing on addressing serious medical needs across various therapeutic areas.

Research and Development

Administration and Support

Clinical and Regulatory Affairs

Research and Development

About

Team members

Other teams at Escient Pharmaceuticals

Administration and Support

Clinical and Regulatory Affairs